- Previous Close
0.1210 - Open
0.1151 - Bid --
- Ask --
- Day's Range
0.1128 - 0.1245 - 52 Week Range
0.0730 - 1.6500 - Volume
425,199 - Avg. Volume
2,198,237 - Market Cap (intraday)
2.246M - Beta (5Y Monthly) 1.37
- PE Ratio (TTM)
-- - EPS (TTM)
-0.8200 - Earnings Date Mar 24, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
0.35
Spineway SA engages in the design, manufacture, and marketing of implants and surgical instruments for treating disorder of spinal column. The company offers ayers rock, an anterior cervical interbody fusion cage; blue mountain, an anterior cervical interbody fusion plate; mont blanc, a posterior thoracolumbar pedicle screws; mont blanc baby, a pediatric growing rod system; mont blanc 3d+, a coplanar alignment system; posterior osteosynthesis systems; kili, an anterior lumbar interbody fusion cage; twin peaks plif posterior lumbar interbody fusion cages; twin peaks tlif transforaminal lumbar interbody fusion cages; and mont blanc mis, a mini-invasive thoracolumbar system. It also provides neve, a biomaterial bone substitute for bone regeneration; and cervical and lumbar prosthesis elastic spine pads. In addition, the company exports its products. Spineway SA was incorporated in 2005 and is headquartered in Ecully, France.
www.spineway.comRecent News: ALSPW.PA
View MorePerformance Overview: ALSPW.PA
Trailing total returns as of 4/4/2025, which may include dividends or other distributions. Benchmark is CAC 40 (^FCHI) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: ALSPW.PA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: ALSPW.PA
View MoreValuation Measures
Market Cap
2.41M
Enterprise Value
2.68M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
0.04
Price/Book (mrq)
0.11
Enterprise Value/Revenue
0.23
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
-32.29%
Return on Assets (ttm)
--
Return on Equity (ttm)
--
Revenue (ttm)
11.95M
Net Income Avi to Common (ttm)
-3.86M
Diluted EPS (ttm)
-0.8200
Balance Sheet and Cash Flow
Total Cash (mrq)
--
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
--